Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

May 01, 1970; Volume 6,Issue 3

Articles

  • You have access
    Electronic Molecular Pharmacology: The Benzothiadiazine Antihypertensive Agents
    ARNOLD J. WOHL
    Molecular Pharmacology May 1970, 6 (3) 189-194;
  • You have access
    Electronic Molecular Pharmacology: The Benzothiadiazine Antihypertensive Agents
    ARNOLD J. WOHL
    Molecular Pharmacology May 1970, 6 (3) 195-205;
  • You have access
    Two-Substrate Kinetics of Drug-Metabolizing Enzyme Systems of Hepatic Microsomes
    ALVITO P. ALVARES and G. J. MANNERING
    Molecular Pharmacology May 1970, 6 (3) 206-212;
  • You have access
    Properties of a Solubilized Form of the Cytochrome P-450-Containing Mixed-Function Oxidase of Liver Microsomes
    ANTHONY Y. H. LU, HENRY W. STROBEL and MINOR J. COON
    Molecular Pharmacology May 1970, 6 (3) 213-220;
  • You have access
    Characteristics of Guinea Pig Liver and Adrenal Monooxygenase Systems
    DAVID KUPFER and STEN ORRENIUS
    Molecular Pharmacology May 1970, 6 (3) 221-230;
  • You have access
    The Effect of 3-Amino-1,2,4-triazole on the Phenobarbital-Induced Formation of Hepatic Microsomal Membranes
    ILENE H. RAISFELD, PAOLO BACCHIN, FERENC HUTTERER and FENTON SCHAFFNER
    Molecular Pharmacology May 1970, 6 (3) 231-239;
  • You have access
    The Binding of Antimalarial Aminoquinolines to Nucleic Acids and Polynucleotides
    CARL R. MORRIS, LIDIA V. ANDREW, LEONA P. WHICHARD and DAVID J. HOLBROOK
    Molecular Pharmacology May 1970, 6 (3) 240-250;
  • You have access
    Thymidine Kinase as a Determinant of the Response to 5-Fluoro-2'-deoxyuridine in Transplantable Murine Leukemias
    DAVID KESSEL and ISIDORE WODINSKY
    Molecular Pharmacology May 1970, 6 (3) 251-254;
  • You have access
    The Interaction of the Nucleoside Analogues, Formycins A and B, with Xanthine Oxidase and Hepatic Aldehyde Oxidase
    M. R. SHEEN, H. F. MARTIN and R. E. PARKS
    Molecular Pharmacology May 1970, 6 (3) 255-265;
  • You have access
    The Effect of Fluoride on the Reaction of Acetylcholinesterase with Carbamates
    CAROL M. GREENSPAN and IRWIN B. WILSON
    Molecular Pharmacology May 1970, 6 (3) 266-272;
  • You have access
    Fluorinated Pyrimidines
    YOSHISADA FUJIWARA, TOSHIKAZU OKI and CHARLES HEIDELBERGER
    Molecular Pharmacology May 1970, 6 (3) 273-280;
  • You have access
    Fluorinated Pyrimidines
    YOSHISADA FUJIWARA and CHARLES HEIDELBERGER
    Molecular Pharmacology May 1970, 6 (3) 281-291;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 6, Issue 3
1 May 1970
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Sign up for alerts

Jump to

  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics